Author:Çakan, Melike Çimen, Bariscan Acar Ozen, Nazire Karabudak, Rana Tuncer, Asli
Session Name:P14: MS Clinical Practice
Topic:MS and Inflammatory Disease
Program Number:P14.016
Author Institution:Hacettepe University Faculty of Medicine Department of Neurology, Ankara, Turkey Hacettepe University Faculty of Medicine Department of Medical Pharmacology, Ankara, Turkey
Author:Wiendl, Heinz De Stefano, Nicola Barkhof, Frederik Montalban, Xavier Achiron, Anat Derfuss, Tobias Chan, Andrew Hodgkinson, Suzanne Prat, Alexandre Leocani, Letizia Schmierer, Klaus Sellebjerg, Finn Vermersch, Patrick Jin, Hulin Jarvinen, Elina Chudecka, Anita Gardner, Lidia
Session Name:S16: MS Clinical Trials and Therapeutics
Topic:MS and Inflammatory Disease
Program Number:S16.006
Author Institution:University of Muenster, Muenster, Germany Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy VU University Medical Center, Amsterdam, Netherlands Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel University Hospital Basel, Basel, Switzerland Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia Université de Montréal, Montreal, QC, Canada Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany Cytel Inc. Geneva, Switzerland, Geneva, Switzerland EMD Serono, Billerica, MA, USA, Billerica, MA
Author:De Stefano, Nicola Achiron, Anat Barkhof, Frederik Chan, Andrew Derfuss, Tobias Hodgkinson, Suzanne Leocani, Letizia Montalban, Xavier Prat, Alexandre Schmierer, Klaus Sellebjerg, Finn Vermersch, Patrick Wiendl, Heinz Keller, Birgit Smyk, Andrzej Gardner, Lidia
Session Name:P6: MS Clinical Trials
Topic:MS and Inflammatory Disease
Program Number:P6.018
Author Institution:Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy Multiple Sclerosis Center, Sheba Academic Medical Center, Ramat Gan, Israel Department of Radiology, VU University Medical Center, Amsterdam, Netherlands Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland Department of Neurology, University Hospital Basel, Basel, Switzerland Ingham Institute for Applied Medical Research, University of New South Wales Medicine, Sydney, Australia Experimental Neurophysiology Unit, Vita-Salute San Raffaele University, Milan, Italy Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Department of Neurosciences, Université de Montréal, Montreal, QC, Canada The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom Danish MS Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France Department of Neurology, Institute of Translational Neurology, University of Münster, Muenster, Germany the healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany EMD Serono Research and Development Institute, Inc., Billerica, MA, USA , Billerica, MA
Author:Bernitsas, Evanthia Reder, Anthony Chinea, Angel Herrman, Craig O'Brien, Barbara Sater, Richard Amezcua, Lilyana Williams, Mitzi Wu, Gregory Vartanian, Timothy Pei, Jinglan Acosta, Juan Monson, Nancy
Session Name:S31: MS Clinical Decision Making and Special Populations
Topic:MS and Inflammatory Disease
Program Number:S31.006
Author Institution:Wayne State University School of Medicine, Detroit, MI University of Chicago Medicine, Oak Park, IL San Juan MS Center, San Juan, PR JWM Neurology, Indianapolis, IN Baptist Memorial Hospital-Collierville, Collierville, TN Cone Health Medical Group, Greensboro, NC Keck School of Medicine, University of Southern California, Los Angeles, CA Joi Life Wellness MS Center, Smyrna, GA Washington University in St Louis, St Louis, MO Brain and Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, NY Genentech, Inc., South San Francisco, CA University of Texas Southwestern, Dallas, TX
Author:Rivier, Cyprien Acosta, Julian Renedo, Daniela Gill, Thomas Sheth, Kevin Falcone, Guido
Session Name:S49: General Neurology
Topic:General Neurology
Program Number:S49.007
Author Institution:Yale University, New Haven, CT Yale, New Haven, CT Yale UniversityDivision of Neuro and Critical Care, New Haven, CT Yale School of Medicine, New Haven, CT